Synthetic curcumin analog UBS109 inhibits the growth of head and neck squamous cell carcinoma xenografts.
Zhu S, Moore TW, Morii N, Howard RB, Culver D, Arrendale RF, Reddy P, Evers TJ, Zhang H, Sica G, Chen ZG, Sun A, Fu H, Khuri FR, Shin DM, Snyder JP, Shoji M.
Zhu S, et al. Among authors: snyder jp.
Curr Cancer Drug Targets. 2014;14(4):380-93. doi: 10.2174/1568009614666140312163524.
Curr Cancer Drug Targets. 2014.
PMID: 24628271